Sandu Pharmaceuticals Limited

BSE: 524703
Sandu Pharmaceuticals Limited - healthcare in Na, Goa, India. FY 2026 financials and compliance.
CIN L24233GA1985PLC001587 Incorporated 15 November 1985 ROC Goa HQ Na, Goa, India
Active Listed - BSE: 524703 Public Limited Company healthcare
Data last updated
Revenue · FY 2026
₹69.93 Cr
▲ 4.08% YoY
EBITDA · FY 2026
₹3.44 Cr
▲ 17.57% YoY
Net profit · FY 2026
₹1.77 Cr
▲ 14.02% YoY
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.66 Cr
Issued & subscribed
Open charges
None
Satisfied ₹53.06 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
295
Latest available

About Sandu Pharmaceuticals Limited

Data last updated: 23 December 2025

Sandu Pharmaceuticals Limited is a public limited company based in Na, Goa, India. It specialises in ayurvedic products and services, a part of the broader healthcare sector. Incorporated on 15 November 1985, the company has been in operation for over 41 years.

Registered with ROC Goa under CIN L24233GA1985PLC001587. Listed on BSE: 524703.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.66 Cr. Formerly known as Sandu Pharmaceuticals Private Limited and Samartha Sandu Pharmaceuticals Private Limited. It is led by directors including Shashank Bhaskar Sandu and Balram Viswanathan.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.25 26 29 & 30 Pilerne Industrial Estate Marra Bardez Goa – 403 511., Na, Goa, India.

As per the financials filed for FY 2025, the company reported a revenue of ₹67.36 Cr, a decline of 1% compared to the previous year.

The company has a workforce of approximately 295 employees as per the latest available data. Its group structure includes 1 subsidiary.

The company is associated with 2 brands - Naattumarundhukadai, Sandu Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹53.06 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sandu.in.

Company Details of Sandu Pharmaceuticals Limited
CIN L24233GA1985PLC001587
Registration Number 001587
Incorporation Date 15 November 1985
ROC Goa
Listing Status Listed (BSE: 524703)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Umesh Bhaskar Sandu Managing Director Shashank Bhaskar Sandu Director Balram Viswanathan Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    sandu.in
  • Social Media
  • Registered Address
    Plot No.25 26 29 & 30 Pilerne Industrial Estate Marra Bardez Goa – 403 511., Na, Goa, India
  • Industry
    Healthcare, Ayurvedic Products & Services
Company report
Sandu Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sandu Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Sandu Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Sandu Pharmaceuticals Limited

Sandu Pharmaceuticals Limited has undergone 2 name changes throughout its history. The company was previously known as Sandu Pharmaceuticals Private Limited, and Samartha Sandu Pharmaceuticals Private Limited. The current legal name is Sandu Pharmaceuticals Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Sandu Pharmaceuticals Limited Current
Sandu Pharmaceuticals Private Limited Previous
Samartha Sandu Pharmaceuticals Private Limited Previous

Associated Brands with Sandu Pharmaceuticals Limited

Sandu Pharmaceuticals Limited operates two associated brands: NaattuMarundhuKadai and Sandu Pharmaceuticals. These brands represent Sandu Pharmaceuticals Limited's diversified market presence and brand portfolio.

Brand Description Website
NaattuMarundhuKadai
Online retailer of herbal medicines, Ayurvedic products, and health supplements. naattumarundhukadai.com
Sandu Pharmaceuticals
Ayurvedic health and wellness products are manufactured in India. sandu.in

Business Activity of Sandu Pharmaceuticals Limited

Sandu Pharmaceuticals Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Sandu Pharmaceuticals Limited

Sandu Pharmaceuticals Limited is audited by M/S Dileep and Prithvi (ICAI peer reviewed, certificate valid till 2026-10-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/S Dileep and Prithvi (ICAI peer reviewed, certificate valid till 2026-10-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Sandu Pharmaceuticals Limited

Sandu Pharmaceuticals Limited is currently managed by 10 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Shashank Bhaskar Sandu
Also directs: Pharmaceuticals Export Promotion Council Of India, Sandu Brothers Private Limited
Director 01 Jun 2011 15 Years 1 Months Current
Balram Viswanathan Director 14 Aug 2023 2 Years 10 Months Current
Ajit Rajaram Kantak Director 14 Aug 2023 2 Years 10 Months Current
Jayshree Bhasker Sandu Director 30 Sep 2024 1 Years 9 Months Current
Shubhada Prabhakar Sandu Director 01 Apr 2015 11 Years 3 Months Current
Umesh Bhaskar Sandu Managing Director 23 Mar 1992 34 Years 3 Months Current
Showing 6 of 10 current directors. View all directors

Financials of Sandu Pharmaceuticals Limited FY 2026 filings available

Sandu Pharmaceuticals Limited reported revenue of ₹69.93 Cr (up 4.08% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹69.93 Cr ▲ 4.08%
Profit · FY 2026
₹1.77 Cr ▲ 14.02%
EBITDA · FY 2026
₹3.44 Cr ▲ 17.57%
Revenue₹ Cr · Standalone0255075FY 2019: ₹49 Cr49.4FY 2019FY 2020: ₹48 Cr · -2.1% YoY48.4-2.1%FY 2020FY 2021: ₹59 Cr · +21.5% YoY58.8+21.5%FY 2021FY 2022: ₹66 Cr · +11.5% YoY65.5+11.5%FY 2022FY 2023: ₹65 Cr · -0.2% YoY65.3-0.2%FY 2023FY 2024: ₹67 Cr · +3% YoY67.3+3%FY 2024FY 2025: ₹67 Cr · -0.1% YoY67.2-0.1%FY 2025FY 2026: ₹70 Cr · +4.1% YoY69.9+4.1%FY 2026
Net Profit₹ Cr · Standalone012FY 2019: ₹1 Cr0.7FY 2019FY 2020: ₹1 Cr · +7.7% YoY0.7+7.7%FY 2020FY 2021: ₹1 Cr · +51.7% YoY1.1+51.7%FY 2021FY 2022: ₹2 Cr · +45.5% YoY1.6+45.5%FY 2022FY 2023: ₹2 Cr · -4.1% YoY1.5-4.1%FY 2023FY 2024: ₹1 Cr · -4.2% YoY1.5-4.2%FY 2024FY 2025: ₹2 Cr · +6.1% YoY1.5+6.1%FY 2025FY 2026: ₹2 Cr · +14% YoY1.8+14%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year01020Q1'25: ₹17 Cr17Q1'25Q2'25: ₹18 Cr17.7Q2'25Q3'25: ₹18 Cr18.4Q3'25Q4'25: ₹14 Cr14.1Q4'25Q1'26: ₹17 Cr · -2% YoY16.7-2%Q1'26Q2'26: ₹18 Cr · -0.5% YoY17.6-0.5%Q2'26Q3'26: ₹19 Cr · +2.1% YoY18.8+2.1%Q3'26Q4'26: ₹17 Cr · +19.8% YoY16.9+19.8%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹69.93 Cr ₹67.19 Cr ₹67.28 Cr ₹65.35 Cr ₹65.5 Cr ₹58.76 Cr ₹48.37 Cr ₹49.42 Cr
Other Income ₹44.44 Lakh ₹16.75 Lakh ₹42.13 Lakh ₹32.72 Lakh ₹8.28 Lakh ₹19.34 Lakh ₹45.27 Lakh ₹57.4 Lakh
Total Income ₹70.38 Cr ₹67.36 Cr ₹67.7 Cr ₹65.68 Cr ₹65.58 Cr ₹58.95 Cr ₹48.82 Cr ₹50 Cr
Cost of Materials Consumed ₹11.01 Cr ₹10.12 Cr ₹9.85 Cr ₹11.13 Cr ₹14.2 Cr ₹11.87 Cr ₹9.14 Cr ₹8.55 Cr
Purchases of Stock-in-Trade ₹16.48 Cr ₹23.18 Cr ₹21.08 Cr ₹23.13 Cr ₹22 Cr ₹19.24 Cr ₹17.01 Cr ₹18.33 Cr
Changes in Inventories ₹4.08 Cr -₹1.2 Cr ₹1.63 Cr -₹3.08 Cr -₹45.43 Lakh ₹3.39 Cr -₹1.03 Cr -₹1.57 Cr
Employee Benefit Expense ₹10.69 Cr ₹10.92 Cr ₹10.07 Cr ₹11.1 Cr ₹8.91 Cr ₹8.02 Cr ₹6.85 Cr ₹6.52 Cr
Finance Costs ₹11.21 Lakh ₹10.33 Lakh ₹6.31 Lakh ₹7.96 Lakh ₹11.16 Lakh ₹11.49 Lakh ₹43.48 Lakh ₹1.01 Cr
Depreciation & Amortisation ₹67.7 Lakh ₹67.06 Lakh ₹58.33 Lakh ₹51.68 Lakh ₹53.01 Lakh ₹55.67 Lakh ₹55.22 Lakh ₹63.58 Lakh
Other Expenses ₹24.67 Cr ₹21.41 Cr ₹22.34 Cr ₹20.57 Cr ₹17.97 Cr ₹14.08 Cr ₹14.95 Cr ₹15.49 Cr
Total Expenses ₹67.72 Cr ₹65.2 Cr ₹65.63 Cr ₹63.46 Cr ₹63.27 Cr ₹57.27 Cr ₹47.9 Cr ₹48.98 Cr
Profit Before Exceptional Items & Tax ₹2.66 Cr ₹2.16 Cr ₹2.07 Cr ₹2.22 Cr ₹2.32 Cr ₹1.68 Cr ₹92.13 Lakh ₹1.02 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 -₹23,000 -₹26,000
Profit Before Tax ₹2.66 Cr ₹2.16 Cr ₹2.07 Cr ₹2.22 Cr ₹2.32 Cr ₹1.68 Cr ₹91.9 Lakh ₹1.02 Cr
Total Tax Expense ₹88.93 Lakh ₹60.69 Lakh ₹61.17 Lakh ₹69.62 Lakh ₹72.73 Lakh ₹58.84 Lakh ₹19.87 Lakh ₹34.86 Lakh
Net Profit ₹1.77 Cr ₹1.55 Cr ₹1.46 Cr ₹1.52 Cr ₹1.59 Cr ₹1.09 Cr ₹72.03 Lakh ₹66.91 Lakh
Other Comprehensive Income ₹66.34 Lakh ₹64.58 Lakh ₹61.49 Lakh ₹56.96 Lakh ₹36.75 Lakh ₹52.41 Lakh -₹27.25 Lakh ₹3.72 Lakh
Total Comprehensive Income ₹2.43 Cr ₹2.19 Cr ₹2.08 Cr ₹2.09 Cr ₹1.96 Cr ₹1.62 Cr ₹44.78 Lakh ₹70.63 Lakh
EBITDA (computed) ₹3.44 Cr ₹2.93 Cr ₹2.72 Cr ₹2.82 Cr ₹2.96 Cr ₹2.35 Cr ₹1.91 Cr ₹2.67 Cr
Basic EPS ₹1.83 ₹1.60 ₹1.51 ₹1.62 ₹1.99 ₹1.54 ₹1.02 ₹0.94
Diluted EPS ₹1.83 ₹1.60 ₹1.51 ₹1.62 ₹1.87 ₹1.54 ₹1.02 ₹0.94
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹55.87 Cr ₹55.72 Cr ₹52.42 Cr ₹54.17 Cr ₹49.28 Cr ₹46.96 Cr ₹41.41 Cr ₹43.64 Cr
Non-current Assets ₹30.55 Cr ₹29.42 Cr ₹19.69 Cr ₹18.98 Cr ₹25.64 Cr ₹16.42 Cr ₹18.99 Cr ₹23.56 Cr
Current Assets ₹25.32 Cr ₹26.3 Cr ₹32.72 Cr ₹35.19 Cr ₹23.65 Cr ₹30.54 Cr ₹22.42 Cr ₹20.08 Cr
Property, Plant & Equipment ₹8.68 Cr ₹8.47 Cr ₹8.41 Cr ₹7.22 Cr ₹6.47 Cr ₹6.47 Cr ₹16.5 Cr ₹16.92 Cr
Inventories ₹10.47 Cr ₹14.15 Cr ₹12.25 Cr ₹14.33 Cr ₹11.27 Cr ₹11.14 Cr ₹14.36 Cr ₹13.26 Cr
Trade Receivables ₹5.41 Cr ₹4.76 Cr ₹4.87 Cr ₹4.79 Cr ₹3.99 Cr ₹5.35 Cr ₹4.68 Cr ₹4.8 Cr
Cash & Equivalents ₹5.91 Cr ₹1.3 Cr ₹99.55 Lakh ₹2.27 Cr ₹93.86 Lakh ₹4.53 Cr ₹1.22 Cr ₹74.09 Lakh
Equity (Net Worth) ₹43.67 Cr ₹42.02 Cr ₹40.6 Cr ₹39.24 Cr ₹36.47 Cr ₹33.49 Cr ₹29.24 Cr ₹28.79 Cr
Equity Share Capital ₹9.66 Cr ₹9.66 Cr ₹9.66 Cr ₹9.66 Cr ₹8.81 Cr ₹7.92 Cr ₹7.08 Cr ₹7.08 Cr
Borrowings (Non-current) ₹30.95 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹17.65 Lakh
Borrowings (Current) ₹10.98 Lakh ₹5.82 Lakh ₹30,000 ₹0 ₹0 ₹1.93 Lakh ₹1.25 Cr ₹5.93 Cr
Total Debt (computed) ₹41.93 Lakh ₹5.82 Lakh ₹30,000 ₹0 ₹0 ₹1.93 Lakh ₹1.25 Cr ₹6.1 Cr
Current Liabilities ₹10.42 Cr ₹12.09 Cr ₹10.64 Cr ₹13.88 Cr ₹11.87 Cr ₹12.52 Cr ₹11.33 Cr ₹13.86 Cr
Total Liabilities ₹12.2 Cr ₹13.7 Cr ₹11.82 Cr ₹14.92 Cr ₹12.81 Cr ₹13.47 Cr ₹12.18 Cr ₹14.85 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹6.12 Cr ₹95.04 Lakh ₹76.13 Lakh ₹22.11 Lakh ₹94,868 Cr
Investing Cash Flow -₹56.88 Lakh -₹17.96 Lakh -₹1.31 Cr ₹52.66 Lakh -₹547,198 Cr
Financing Cash Flow -₹94.32 Lakh -₹46.24 Lakh -₹72.44 Lakh ₹57.91 Lakh ₹93,433 Cr
Capital Expenditure ₹72 Lakh ₹93.8 Lakh ₹1.43 Cr ₹1.07 Cr ₹84,096 Cr
Free Cash Flow (computed) ₹5.4 Cr ₹1.24 Lakh -₹66.38 Lakh -₹84.77 Lakh ₹10,772 Cr
Dividends Paid ₹77.29 Lakh ₹77.29 Lakh ₹72.46 Lakh ₹66.08 Lakh ₹31,693 Cr
Net Change in Cash ₹4.6 Cr ₹30.84 Lakh -₹1.27 Cr ₹1.33 Cr -₹358,897 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹16.85 Cr ₹18.76 Cr ₹17.62 Cr ₹16.7 Cr ₹14.07 Cr ₹18.37 Cr ₹17.7 Cr ₹17.05 Cr
Other Income ₹36.51 Lakh ₹1.37 Lakh ₹4.79 Lakh ₹1.77 Lakh ₹6.93 Lakh ₹2.45 Lakh ₹2.87 Lakh ₹4.49 Lakh
Total Income ₹17.22 Cr ₹18.77 Cr ₹17.67 Cr ₹16.72 Cr ₹14.14 Cr ₹18.4 Cr ₹17.73 Cr ₹17.09 Cr
Cost of Materials Consumed ₹3.84 Cr ₹2.81 Cr ₹2.45 Cr ₹1.91 Cr ₹3.01 Cr ₹2.39 Cr ₹2.44 Cr ₹2.27 Cr
Purchases of Stock-in-Trade ₹3.52 Cr ₹3.5 Cr ₹5.88 Cr ₹3.59 Cr ₹7.29 Cr ₹6.55 Cr ₹5.41 Cr ₹3.94 Cr
Changes in Inventories -₹83.01 Lakh ₹1.57 Cr ₹2,000 ₹3.33 Cr -₹4.53 Cr -₹7.74 Lakh ₹31.58 Lakh ₹3.08 Cr
Employee Benefit Expense ₹2.74 Cr ₹2.65 Cr ₹2.64 Cr ₹2.66 Cr ₹2.83 Cr ₹3.16 Cr ₹2.61 Cr ₹2.33 Cr
Finance Costs ₹2.56 Lakh ₹3.35 Lakh ₹2.66 Lakh ₹2.64 Lakh ₹2.63 Lakh ₹2.74 Lakh ₹2.83 Lakh ₹2.13 Lakh
Depreciation & Amortisation ₹16.49 Lakh ₹16.58 Lakh ₹16.87 Lakh ₹17.76 Lakh ₹14.81 Lakh ₹18.96 Lakh ₹17.41 Lakh ₹15.88 Lakh
Other Expenses ₹7.01 Cr ₹7.19 Cr ₹5.79 Cr ₹4.68 Cr ₹5.02 Cr ₹5.36 Cr ₹6.02 Cr ₹5.01 Cr
Total Expenses ₹16.47 Cr ₹17.92 Cr ₹16.95 Cr ₹16.38 Cr ₹13.8 Cr ₹17.6 Cr ₹16.99 Cr ₹16.82 Cr
Profit Before Exceptional Items & Tax ₹74.71 Lakh ₹85.5 Lakh ₹71.45 Lakh ₹33.87 Lakh ₹34.24 Lakh ₹79.85 Lakh ₹74.38 Lakh ₹27.1 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹74.71 Lakh ₹85.5 Lakh ₹71.45 Lakh ₹33.87 Lakh ₹34.24 Lakh ₹79.85 Lakh ₹74.38 Lakh ₹27.1 Lakh
Total Tax Expense ₹70.37 Lakh -₹12.01 Lakh ₹19.02 Lakh ₹11.54 Lakh ₹1.6 Lakh ₹24.3 Lakh ₹24.37 Lakh ₹10.42 Lakh
Net Profit ₹4.34 Lakh ₹97.51 Lakh ₹52.43 Lakh ₹22.33 Lakh ₹32.64 Lakh ₹55.55 Lakh ₹50.01 Lakh ₹16.68 Lakh
Other Comprehensive Income ₹66.34 Lakh ₹16.96 Lakh ₹13.88 Lakh ₹10.33 Lakh ₹9.84 Lakh ₹18.25 Lakh ₹17.72 Lakh ₹18.77 Lakh
Total Comprehensive Income ₹70.68 Lakh ₹1.14 Cr ₹66.31 Lakh ₹32.66 Lakh ₹42.48 Lakh ₹73.8 Lakh ₹67.73 Lakh ₹35.45 Lakh
EBITDA (computed) ₹93.76 Lakh ₹1.05 Cr ₹90.98 Lakh ₹54.27 Lakh ₹51.68 Lakh ₹1.02 Cr ₹94.62 Lakh ₹45.11 Lakh
Basic EPS ₹0.04 ₹1.01 ₹0.54 ₹0.23 ₹0.34 ₹0.57 ₹0.52 ₹0.17
Diluted EPS ₹0.04 ₹1.01 ₹0.54 ₹0.23 ₹0.34 ₹0.57 ₹0.52 ₹0.17
Latest 8 quarters shown.
Metrics FY 2025 FY 2024 FY 2023
Revenue from Operations ₹67.19 Cr ₹67.28 Cr ₹65.35 Cr
Other Income ₹16.75 Lakh ₹42.36 Lakh ₹32.72 Lakh
Total Income ₹67.36 Cr ₹67.7 Cr ₹65.68 Cr
Cost of Materials Consumed ₹10.12 Cr ₹9.85 Cr ₹11.13 Cr
Purchases of Stock-in-Trade ₹23.18 Cr ₹21.08 Cr ₹23.13 Cr
Changes in Inventories -₹1.2 Cr ₹1.63 Cr -₹3.08 Cr
Employee Benefit Expense ₹10.92 Cr ₹10.07 Cr ₹11.1 Cr
Finance Costs ₹10.33 Lakh ₹6.3 Lakh ₹7.96 Lakh
Depreciation & Amortisation ₹67.06 Lakh ₹58.33 Lakh ₹51.68 Lakh
Other Expenses ₹21.41 Cr ₹22.34 Cr ₹20.58 Cr
Total Expenses ₹65.2 Cr ₹65.63 Cr ₹63.46 Cr
Profit Before Exceptional Items & Tax ₹2.16 Cr ₹2.07 Cr ₹2.22 Cr
Exceptional Items ₹0 ₹0 ₹0
Profit Before Tax ₹2.16 Cr ₹2.07 Cr ₹2.22 Cr
Total Tax Expense ₹60.68 Lakh ₹61.17 Lakh ₹69.66 Lakh
Net Profit ₹1.55 Cr ₹1.46 Cr ₹1.52 Cr
  attributable to Owners - ₹0 ₹0
  attributable to NCI - ₹0 ₹0
Other Comprehensive Income ₹64.58 Lakh ₹61.49 Lakh ₹56.96 Lakh
Total Comprehensive Income ₹2.2 Cr ₹2.08 Cr ₹2.09 Cr
EBITDA (computed) ₹2.93 Cr ₹2.72 Cr ₹2.81 Cr
Basic EPS ₹1.60 ₹1.51 ₹1.61
Diluted EPS ₹1.60 ₹1.51 ₹1.61
Metrics FY 2025 FY 2024 FY 2023
Total Assets ₹55.72 Cr ₹52.41 Cr ₹54.17 Cr
Non-current Assets ₹29.42 Cr ₹19.69 Cr ₹28.62 Cr
Current Assets ₹26.3 Cr ₹32.72 Cr ₹25.55 Cr
Property, Plant & Equipment ₹8.47 Cr ₹8.41 Cr ₹7.22 Cr
Inventories ₹14.15 Cr ₹12.25 Cr ₹14.33 Cr
Trade Receivables ₹4.76 Cr ₹4.87 Cr ₹4.79 Cr
Cash & Equivalents ₹1.3 Cr ₹1 Cr ₹2.28 Cr
Equity (Net Worth) ₹42.02 Cr ₹40.59 Cr ₹39.24 Cr
Equity Share Capital ₹9.66 Cr ₹9.66 Cr ₹9.66 Cr
Borrowings (Non-current) ₹41.93 Lakh ₹0 ₹0
Borrowings (Current) ₹5.82 Lakh ₹30,000 ₹0
Total Debt (computed) ₹47.75 Lakh ₹30,000 ₹0
Current Liabilities ₹12.09 Cr ₹10.64 Cr ₹13.88 Cr
Total Liabilities ₹13.7 Cr ₹11.82 Cr ₹14.93 Cr
Metrics FY 2025 FY 2024 FY 2023
Operating Cash Flow ₹94.84 Lakh ₹76.01 Lakh ₹22.12 Lakh
Investing Cash Flow -₹18.62 Lakh -₹1.31 Cr ₹53.66 Lakh
Financing Cash Flow -₹46.24 Lakh -₹72.44 Lakh ₹57.91 Lakh
Capital Expenditure ₹93.8 Lakh ₹1.43 Cr ₹1.07 Cr
Free Cash Flow (computed) ₹1.04 Lakh -₹66.5 Lakh -₹84.76 Lakh
Dividends Paid ₹77.29 Lakh ₹72.46 Lakh ₹66.08 Lakh
Net Change in Cash ₹29.98 Lakh -₹1.27 Cr ₹1.34 Cr
Metrics Q4 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹14.07 Cr ₹17.7 Cr ₹17.05 Cr
Other Income ₹6.94 Lakh ₹2.87 Lakh ₹4.49 Lakh
Total Income ₹14.14 Cr ₹17.73 Cr ₹17.09 Cr
Cost of Materials Consumed ₹3.01 Cr ₹2.44 Cr ₹2.27 Cr
Purchases of Stock-in-Trade ₹7.29 Cr ₹5.41 Cr ₹3.94 Cr
Changes in Inventories -₹4.53 Cr ₹31.58 Lakh ₹3.08 Cr
Employee Benefit Expense ₹2.83 Cr ₹2.61 Cr ₹2.33 Cr
Finance Costs ₹2.63 Lakh ₹2.83 Lakh ₹2.12 Lakh
Depreciation & Amortisation ₹14.81 Lakh ₹17.41 Lakh ₹15.88 Lakh
Other Expenses ₹5.02 Cr ₹6.03 Cr ₹5.01 Cr
Total Expenses ₹13.8 Cr ₹17 Cr ₹16.82 Cr
Profit Before Exceptional Items & Tax ₹34.26 Lakh ₹73.69 Lakh ₹27.07 Lakh
Exceptional Items ₹0 ₹0 ₹0
Profit Before Tax ₹34.26 Lakh ₹73.69 Lakh ₹27.07 Lakh
Total Tax Expense ₹1.6 Lakh ₹24.17 Lakh ₹10.4 Lakh
Net Profit ₹32.66 Lakh ₹49.52 Lakh ₹16.67 Lakh
  attributable to Owners - - ₹0
  attributable to NCI - - ₹0
Other Comprehensive Income ₹9.84 Lakh ₹17.72 Lakh ₹18.83 Lakh
Total Comprehensive Income ₹42.5 Lakh ₹67.24 Lakh ₹35.5 Lakh
EBITDA (computed) ₹51.7 Lakh ₹93.93 Lakh ₹45.07 Lakh
Basic EPS ₹0.34 ₹0.52 ₹0.17
Diluted EPS ₹0.34 ₹0.52 ₹0.17
Latest 3 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Sandu Pharmaceuticals Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Sandu Pharmaceuticals Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 37.79%, domestic institutional investors hold 0.01%, retail and other public shareholders hold 62.21% of Sandu Pharmaceuticals Limited. The company had 10,298 shareholders on record.

Promoters: 37.79%DII (Domestic Institutional): 0.01%Retail & Others: 62.21%
Mar 2026
QUARTER
37.79% Promoters
0.01% DII (Domestic Institutional)
62.21% Retail & Others
Promoter holding - history
Now 37.79% · Mar 2026High 52.41% · Jun 2023Low 37.79% · Dec 2025
36%40.5%45%49.5%54%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 52.41%Sep 2023: 42.90%Dec 2023: 42.90%Mar 2024: 42.90%Jun 2024: 42.90%Sep 2024: 42.90%Dec 2024: 42.90%Mar 2025: 42.90%Jun 2025: 42.90%Sep 2025: 42.90%Dec 2025: 37.79%Mar 2026: 37.79%52.41%37.79%37.79%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters37.79%37.79%42.90%42.90%42.90%42.90%
Public62.21%62.21%57.10%57.10%57.10%57.10%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters37.79%42.90%42.90%
Public62.21%57.10%57.10%
Promoter change (YoY, %pts)-5.11+0.00-

Group Structure of Sandu Pharmaceuticals Limited

Sandu Pharmaceuticals Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Sandu Pharmaceuticals Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Sandu Phytoceuticals Private Limited U24230GA2022PTC015422 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Sandu Pharmaceuticals Limited

Open charges
₹0
Satisfied charges
₹53.06 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹18.00 Cr
Axis Bank Limited₹17.25 Cr
Dena Bank₹16.61 Cr
Dena Bank (Industrial Finance Branch)₹1.20 Cr
Latest charge details
DateLenderAmountStatus
09 Jul 2021 Hdfc Bank Limited ₹18 Cr Satisfied
24 Sep 2018 Axis Bank Limited ₹14.75 Cr Satisfied
12 Apr 2011 Dena Bank ₹1.91 Cr Satisfied
21 Dec 2010 Dena Bank ₹10 Cr Satisfied
30 Apr 2008 Axis Bank Limited ₹2.5 Cr Satisfied

Total charge records: 9 View all charges

Employees and EPFO Compliance at Sandu Pharmaceuticals Limited

Sandu Pharmaceuticals Limited has a workforce of 295 employees as of Mar 31, 2024.

Employee count
295
Active EPFO establishments
3
Employee growth
-6.35%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Sandu Pharmaceuticals Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Sandu Pharmaceuticals Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Sandu Pharmaceuticals Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Sandu Pharmaceuticals Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Sandu Pharmaceuticals Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Sandu Pharmaceuticals Limited

MSME Payment Delays by Sandu Pharmaceuticals Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Sandu Pharmaceuticals Limited

Subsidiaries & Group Companies of Sandu Pharmaceuticals Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Sandu Pharmaceuticals Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Sandu Pharmaceuticals Limited

MCA Filings & Documents of Sandu Pharmaceuticals Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Sandu Pharmaceuticals Limited

Activity
30 Sep 2025
Sandu Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Sandu Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Goa.
Directors
30 Sep 2024
Jayshree Bhasker Sandu was appointed as a Director on 30 Sep 2024 & has been associated with this company since 1 year 9 months.
Directors
12 Aug 2024
Vijay Kottapalli was appointed as a Director on 12 Aug 2024 & has been associated with this company since 1 year 10 months.
Directors
11 Apr 2024
Vijay Yashwant Kajarekar was appointed as a Cfo on 11 Apr 2024 & has been associated with this company since 2 years 2 months.
Directors
14 Aug 2023
Balram Viswanathan was appointed as a Director on 14 Aug 2023 & has been associated with this company since 2 years 10 months.

Recent News on Sandu Pharmaceuticals Limited

Frequently Asked Questions about Sandu Pharmaceuticals Limited

Sandu Pharmaceuticals Limited is an active public limited company in the healthcare sector based in Na, Goa, India. It was incorporated on 15 November 1985 (41+ years old) and is registered under CIN L24233GA1985PLC001587. Listed on BSE: 524703. The company has 295 employees.

Sandu Pharmaceuticals Limited reported revenue of ₹67.36 Cr for FY 2025 (down 1.00% YoY).

The current directors of Sandu Pharmaceuticals Limited are:

The primary industry of Sandu Pharmaceuticals Limited is healthcare. The company specifically operates in ayurvedic products and services. The company is currently active in this sector.

Yes. Sandu Pharmaceuticals Limited is listed on BSE with code 524703.

Sandu Pharmaceuticals Limited can be reached at the registered office: Plot No.25 26 29 & 30 Pilerne Industrial Estate Marra Bardez Goa – 403 511, Na, Goa, India, or through the website sandu.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available